Winnipeg, Canada

Aaron Marshall


Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Aaron Marshall in Immunology

Introduction

Aaron Marshall is a notable inventor based in Winnipeg, Canada. He has made significant contributions to the field of immunology, particularly in the treatment of disorders involving immunoglobulin A. With a total of 3 patents to his name, his work has the potential to impact the medical community significantly.

Latest Patents

Marshall's latest patents focus on methods for treating disorders that involve immunoglobulin A. These patents provide detailed descriptions of FDC-SP polypeptides and their applications. The methods outlined include altering IgA concentration in a subject, treating individuals with excessive IgA production, and identifying compounds that can decrease IgA levels in animals. Additionally, the patents describe an animal model with decreased expression of an endogenous FDC-SP coding sequence, which may exhibit pathophysiological features of IgA nephropathy. This model can also display increased IgA in various biological fluids and heightened IgA production by isolated B lymphocytes.

Career Highlights

Throughout his career, Aaron Marshall has worked with prestigious institutions such as the University of Manitoba and the University of Washington. His research has been instrumental in advancing our understanding of immunological disorders and developing innovative treatment methods.

Collaborations

Some of his notable coworkers include Sen Hou and Edward A Clark. Their collaborative efforts have contributed to the success of Marshall's research and patent applications.

Conclusion

Aaron Marshall's innovative work in immunology, particularly regarding immunoglobulin A, showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving treatment options for patients with related disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…